Emerging Knowledge - The Early Indications Of Metachromatic Leukodystrophy (MLD) In Children

30 minutes
English
Rare Diseases
Metachromatic Leukodystrophy
MLD

Metachromatic Leukodystrophy (MLD) is a rare hereditary disease characterized by the accumulation of fats called sulfatides. This causes the destruction of the protective fatty layer (myelin sheath) surrounding the nerves in both the central nervous system and the peripheral nervous system, ultimately affecting intellectual and motor function. Early-onset clinical manifestations are often overlooked or confused with other conditions, confusing non-trained HCPs at first contact, resulting in misdiagnosis, wrong referral routes and delays in the early start of treatment. Delays in starting treatment significantly affect the conditions’ development and the patient’s health and quality of life. This delay in referral and treatment must be overcome.

Learning Objectives

Recapping the main early signs and symptoms of MLD in childrenExamining the latest emerging studies on new signs of MLD and what to look for Understanding the limitations of private tests that only look for a certain number of common mutations - Does a negative genetic text always rules out MLD? Exploring when to refer patients and eliminating the misdiagnoses of MLD with other conditionsCase Study example of Gallbladder abnormalities in children with MLD that occur at a far greater incidence than other LSDs